These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3301601)

  • 1. [Theophylline--once or twice daily?].
    Schoch C; Menz G; Virchow C
    Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dose titration with Euphylong following prior determination of serum concentration in the steady state].
    Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW
    Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 10. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1986 Sep; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pirenzepine in the prevention of gastric intolerance to drugs used in pulmonary pathology].
    Guarino C; Cautiero V; Borrelli G; De los Rios B; Marcatili S; Valentini P
    Minerva Dietol Gastroenterol; 1988; 34(2):129-34. PubMed ID: 3050611
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing.
    Armstrong EP; Nako N; Plezia PM; Kramer TH; Jones WN
    Clin Pharm; 1987 Oct; 6(10):800-4. PubMed ID: 3505842
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.
    Bruguerolle B; Philip-Joet F; Parrel M; Arnaud A
    Chronobiol Int; 1987; 4(3):381-5. PubMed ID: 3315267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.